Pharmaceutical composition comprising a SGLT2 inhibitor in combination with a DPP-IV inhibitor

Details for Australian Patent Application No. 2008288410 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Mark, Michael; Dugi, Klaus; Himmelsbach, Frank

Agent Davies Collison Cave

Pub. Number AU-A-2008288410

PCT Pub. Number WO2009/022010

Priority 07114458.8 16.08.07 EP

Filing date 15 August 2008

Wipo publication date 19 February 2009

International Classifications

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

18 February 2010 PCT application entered the National Phase

  PCT publication WO2009/022010 Priority application(s): WO2009/022010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008288413-Insulin analogues with an acyl and aklylene glycol moiety

2008288407-Pharmaceutical composition comprising a glucopyranosyl-substituted benzene derivative